Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Telogen Effluvium Hair Loss in Covid-19 Patients and Its Relationship With Disease Severity Publisher Pubmed



Seyfi S1 ; Alijanpour R2 ; Aryanian Z3 ; Ezoji K4 ; Mahmoudi M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Anesthesiology, Babol University of Medical Sciences, Babol, Iran
  2. 2. Iranian Medical Laser Association, Babol, Iran
  3. 3. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  5. 5. Clinical Research Development, Unit of Ayatollah Rohani Hospital, Babol University of Medical Sciences, Babol, Iran

Source: Journal of Medicine and Life Published:2022


Abstract

COVID-19 is a concerning global pandemic. Common manifestations are fever and respiratory symptoms. In addition, recent studies reported dermatological manifestations as extrapulmonary signs. One of these is telogen effluvium which is related to post COVID-19 comorbidities. The aim of this study was to assess the prevalence of telogen effluvium among COVID-19 patients. This observational cross-sectional study included 198 patients who were admitted for COVID-19. The PCR test was performed to detect positive cases. After discharge, all patients were inter-viewed about hair loss. Of these patients, 79 were male (39.9%), and 119 were female (60.1%). The age ranged from 18 to 85 years old. 48 patients showed hair loss. Telogen effluvium (TE) is one of the consequences of the COVID-19 pandemic. COVID-19 leads to more medications and stress situations, which trigger TE. © 2022, Carol Davila University Press. All rights reserved.
Related Docs
1. The Role of Sars-Cov-2 Infection and Its Vaccines in Various Types of Hair Loss, Dermatologic Therapy (2022)
2. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
3. Therapeutic Potential of Bromhexine for Acute Itch in Mice: Involvement of Tmprss2 and Kynurenine Pathway, International Immunopharmacology (2023)
Experts (# of related papers)
View all Related Experts
Raziyeh Mohammad Jafari (1)
Zeinab Aryanian (1)